Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Open in API
Filings indexed 1,321 across all filing types
Latest filing 2020-02-03 Transaction in Own Shar…
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Transaction in Own Shares Classification · 99% confidence The document is very short (1487 characters) and contains an RNS Number (8069B) from the London Stock Exchange. The content explicitly discusses a 'Price Monitoring Extension' and mentions that the information is provided by RNS, the news service of the London Stock Exchange, which is approved by the FCA. This is a routine, non-financial operational announcement related to trading mechanics, not a core financial report (like 10-K, IR, ER) or a specific corporate action (like DIV, CAP). Since it is a general regulatory announcement distributed via the RNS system and does not fit into the more specific categories (like DIRS, MANG, DIV), the most appropriate classification is the general Regulatory Filings fallback category.
2020-02-03 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and a date, indicating it is a regulatory announcement. The core content explicitly states the 'Total Voting Rights and Share Capital' as of a specific month-end date (31 January 2020) pursuant to DTR 5.6.1 (Disclosure Guidance and Transparency Rules). This type of disclosure, which reports changes in the total number of shares and voting rights, is a standard regulatory filing related to share structure. While it relates to share capital, it is not a formal share issue/capital change announcement (SHA) but rather a mandatory periodic disclosure of the current total share count. It is also not a Director's Dealing (DIRS) or a Major Shareholding Notification (MRQ), which focus on specific shareholder transactions. Since it is a mandatory regulatory disclosure that doesn't fit perfectly into the other specific categories like DIV, CAP, or SHA, and is clearly sourced from RNS (London Stock Exchange's news service), the most appropriate classification is the general regulatory filing category, RNS, as it is a routine compliance update.
2020-02-03 English
PureTech Receives $200M from KRTX Shares
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated January 23, 2020. It announces a specific corporate action: 'PureTech Receives $200 Million from Sale of a Minority Portion of Affiliate Shares'. This is a material event announcement disseminated via the London Stock Exchange's news service (RNS). The content is a press release detailing a transaction, not a comprehensive financial report (like 10-K or IR) or a transcript. Since it is a general regulatory announcement distributed through the official news service (RNS) and doesn't fit neatly into categories like DIV, CAP, or DIRS, the most appropriate classification is the general regulatory filing/announcement category.
2020-01-23 English
Akili's New ADHD Trial Met Primary Endpoint
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated January 15, 2020. It contains an announcement from PureTech Health plc regarding positive clinical trial results for its affiliate Akili's product AKL-T01. The content is a press release detailing scientific and clinical updates, which is typical for a general regulatory announcement or news service release. Since it is not a full financial report (10-K, IR), a specific financial event (ER, DIV), or a proxy/governance document, and it is explicitly distributed via RNS (London Stock Exchange's news service), the most appropriate classification is Regulatory Filings (RNS), as it serves as a general regulatory disclosure. It is not an Earnings Release (ER) as it focuses on clinical trial data, not period financial results. It is not an Investor Presentation (IP) as it is a text announcement, not a slide deck. It is not a Report Publication Announcement (RPA) because it contains the substantive information itself, rather than just announcing that a report is available.
2020-01-15 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document text is very short (1503 characters) and contains the header 'RNS Number : 6249Z' and mentions 'RNS, the news service of the London Stock Exchange'. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific, immediate operational announcement. This type of short, time-sensitive regulatory notification that doesn't fit into the specific financial report categories (like 10-K, ER, IR) is best classified as a general Regulatory Filing, which corresponds to the RNS code.
2020-01-13 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document contains an 'RNS Number' and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content itself is a brief announcement regarding a 'Price Monitoring Extension' for an auction call period, which is a routine operational update related to trading mechanics rather than a core financial report (like 10-K, IR, or ER). Given its nature as a general regulatory announcement distributed via the RNS service and its brevity (1486 chars), it fits best under the general Regulatory Filings category, which serves as a fallback for miscellaneous regulatory notices.
2020-01-13 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.